These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10617578)

  • 41. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.
    Oliverio MI; Kim HS; Ito M; Le T; Audoly L; Best CF; Hiller S; Kluckman K; Maeda N; Smithies O; Coffman TM
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15496-501. PubMed ID: 9860997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
    Lee MA; Böhm M; Kim S; Bachmann S; Bachmann J; Bader M; Ganten D
    Hypertension; 1995 Apr; 25(4 Pt 1):570-80. PubMed ID: 7721400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes.
    Davisson RL; Yang G; Beltz TG; Cassell MD; Johnson AK; Sigmund CD
    Circ Res; 1998 Nov; 83(10):1047-58. PubMed ID: 9815152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intratubular and intracellular renin-angiotensin system in the kidney: a unifying perspective in blood pressure control.
    Li XC; Zhu D; Zheng X; Zhang J; Zhuo JL
    Clin Sci (Lond); 2018 Jul; 132(13):1383-1401. PubMed ID: 29986878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The renin-angiotensin system of the brain].
    Wiecek A
    Pol Arch Med Wewn; 1983 Jan; 69(1):69-78. PubMed ID: 6310531
    [No Abstract]   [Full Text] [Related]  

  • 47. Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways.
    Kato H; Ishida J; Matsusaka T; Ishimaru T; Tanimoto K; Sugiyama F; Yagami K; Nangaku M; Fukamizu A
    PLoS One; 2015; 10(6):e0129484. PubMed ID: 26107632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
    Hodge G; Ye VZ; Duggan KA
    Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the enzymatic reaction of renin in aggressive mice.
    Poulsen K; Jacobsen J
    J Hypertens; 1986 Apr; 4(2):175-80. PubMed ID: 3519761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary renin-angiotensin markers in polycystic kidney disease.
    Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re-evaluation of the plasma renin-angiotensin system in anephric patients.
    Mizuno K; Higashimori K; Stone WJ; Shimamoto K; Fukuchi S; Inagami T
    Clin Exp Hypertens A; 1990; 12(7):1135-57. PubMed ID: 2257684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of vascular angiotensin release.
    Kato H; Iwai N; Inui H; Kimoto K; Uchiyama Y; Inagami T
    Hypertension; 1993 Apr; 21(4):446-54. PubMed ID: 8458646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet.
    Carillo BA; Beutel A; Mirandola DA; Vidonho AF; Furukawa LN; Casarini D; Campos RR; Dolnikoff MS; Heimann JC; Bergamaschi CT
    Regul Pept; 2007 Apr; 140(1-2):5-11. PubMed ID: 17196676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control.
    Dzau VJ
    J Hypertens Suppl; 1988 Dec; 6(3):S7-12. PubMed ID: 3066879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age dependence of human plasma renin substrate.
    Immonen I; Fyhrquist F; Pohjavuori M; Simell O
    Scand J Clin Lab Invest; 1981 Apr; 41(2):167-70. PubMed ID: 7031835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The renin-angiotensin system and body function.
    Reid IA
    Arch Intern Med; 1985 Aug; 145(8):1475-9. PubMed ID: 2992406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule.
    Lavoie JL; Lake-Bruse KD; Sigmund CD
    Am J Physiol Renal Physiol; 2004 May; 286(5):F965-71. PubMed ID: 15075192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose effects of human renin in rats transgenic for human angiotensinogen.
    Bohlender J; Ménard J; Luft FC; Ganten D
    Hypertension; 1997 Apr; 29(4):1031-8. PubMed ID: 9095095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.